Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)
Our Collection of ASCO 2012 Lung Cancer Highlights Podcasts
Dr West
Please Note: New Treatments Have Emerged Since this Original Post
We've been producing a series of podcasts from our Lung Cancer Highlights from ASCO 2012 webinar, featuring Drs. Mark Socinski, from the University of Pittsburgh, and Joel Neal, from Stanford Cancer Center. This program, and the series of podcasts produced from it, is part of our partnership of GRACE with the LUNGevity Foundation.
Here is the current list of the series of podcasts:
Dr. Socinski:
The PARAMOUNT trial of maintenance Alimta (pemetrexed)
Optimal chemo for marginal performance status patients with advanced NSCLC
Update on critical small cell lung cancer trials from ASCO 2012
Dr. Neal:
Anti-PD1 Immunotherapy for Advanced NSCLC
Anti-MEK agent selumetinib for KRAS mutation-positive advanced NSCLC
We've got just a few more to add from Dr. Neal, followed by a podcast that covers the question and answer session from this webinar.
What rank as your favorite highlights? Do you find this information to be encouraging, whether for immediate new possibilities or for longer term prospects for lung cancer?
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Image
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Image
Video
The Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025 has now ended.
¡Los vídeos están disponibles BAJO DEMANDA!
Las versiones completas sin editar del Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón de agosto de 2025 ya están disponibles BAJO DEMANDA. Estos temas se editarán y se ofrecerán en forma de vídeos más cortos en las próximas semanas.
Image
Article
Da click aquí para más información y para registrarte ahora
Online Community
Hi app.92, Welcome to Grace. I'm sorry this is late getting to you. And more sorry your mum is going through this. It's possible this isn't a pancoast tumor even though...
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
Here's the webinar on YouTube. It begins with the agenda. Note the link is a playlist, which will be populated with shorts from the webinar on specific topics
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
- The antibody, which serves as the “horse,” specifically targets a protein found on cancer...